Strain identifier

BacDive ID: 12636

Type strain: Yes

Species: Cutibacterium acnes

Strain history: CIP <- 1953, NCTC <- F. Hayden, London, UK

NCBI tax ID(s): 1747 (species)

For citation purpose refer to the digital object identifier (doi) of the current version.
Archive
version 8.1 (current version):
version 8:
version 7.1:
version 7:
version 6:
version 5:
version 4.1:
version 4:
version 3:
version 2.1:
version 2:
version 1:
version 8.1 (current version)

General

@ref: 919

BacDive-ID: 12636

DSM-Number: 1897

keywords: genome sequence, 16S sequence, Bacteria, anaerobe, mesophilic, Gram-positive, rod-shaped

description: Cutibacterium acnes LMG 16711 is an anaerobe, mesophilic, Gram-positive bacterium that was isolated from acne lesion in human facial skin.

NCBI tax id

  • NCBI tax id: 1747
  • Matching level: species

strain history

@refhistory
919<- ATCC; ATCC 6919 <- NCTC; NCTC 737 <- A. Hayden; (Corynebacterium acnes)
67770T. Mitsuoka <-- ATCC 6919 <-- NCTC 737 ("Corynebacterium acnes") <-- A. Hayden.
116031CIP <- 1953, NCTC <- F. Hayden, London, UK

doi: 10.13145/bacdive12636.20230509.8.1

Name and taxonomic classification

LPSN

  • @ref: 20215
  • description: domain/bacteria
  • keyword: phylum/actinomycetota
  • domain: Bacteria
  • phylum: Actinomycetota
  • class: Actinomycetes
  • order: Propionibacteriales
  • family: Propionibacteriaceae
  • genus: Cutibacterium
  • species: Cutibacterium acnes
  • full scientific name: Cutibacterium acnes (Gilchrist 1900) Scholz and Kilian 2016
  • synonyms

    @refsynonym
    20215Bacillus acnes
    20215Propionibacterium acnes

@ref: 919

domain: Bacteria

phylum: Actinobacteria

class: Actinobacteria

order: Actinomycetales

family: Propionibacteriaceae

genus: Cutibacterium

species: Cutibacterium acnes subsp. acnes

full scientific name: Cutibacterium acnes subsp. acnes (Gilchrist 1900) Nouioui et al. 2018 emend. Dekio et al. 2019

type strain: yes

Morphology

cell morphology

@refgram staincell lengthcell widthcell shapemotilityconfidence
24963positive0.8-0.9 µm0.4-0.5 µmrod-shapedno
24963ellipsoidal
69480no94.971
69480positive100
116031positiverod-shapedno

colony morphology

@reftype of hemolysishemolysis abilitycolony sizecolony colorincubation periodcolony shapemedium used
24963beta1<4.0 mmwhite,tan, pink or orange21 days
24963beta1<5.0 mmwhite-to-graycircularblood agar (horse or rabbit)
444232-3 days
116031

Culture and growth conditions

culture medium

@refnamegrowthlinkcomposition
919COLUMBIA BLOOD MEDIUM (DSMZ Medium 693)yeshttps://mediadive.dsmz.de/medium/693Name: COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) Composition: Defibrinated sheep blood 50.0 g/l Columbia agar base
919PYG MEDIUM (MODIFIED) (DSMZ Medium 104)yeshttps://mediadive.dsmz.de/medium/104Name: PYG MEDIUM (modified) (DSMZ Medium 104) Composition: Yeast extract 10.0 g/l Peptone 5.0 g/l Trypticase peptone 5.0 g/l Beef extract 5.0 g/l Glucose 5.0 g/l L-Cysteine HCl x H2O 0.5 g/l NaHCO3 0.4 g/l NaCl 0.08 g/l K2HPO4 0.04 g/l KH2PO4 0.04 g/l MgSO4 x 7 H2O 0.02 g/l CaCl2 x 2 H2O 0.01 g/l Hemin 0.005 g/l Ethanol 0.0038 g/l Resazurin 0.001 g/l Tween 80 Vitamin K1 NaOH Distilled water
24963blood agar (horse or rabbit)yes
42199MEDIUM 20 - for Anaerobic bacteriayesAgar (15.000 g);Glucose (5.000 g);Yeast extract (20.000 g);Tryptone (30.000 g);Cysteine hydrochloride (0.500 g);distilled water (1000.000 ml);Hemin solution -M00149 (25.000 ml)
116031CIP Medium 20yeshttps://catalogue-crbip.pasteur.fr/fiche_milieu.xhtml?crbip=20

culture temp

@refgrowthtypetemperaturerange
24963positiveoptimum30.0-37.0mesophilic
42199positivegrowth37mesophilic
44423positivegrowth37mesophilic
67770positivegrowth37mesophilic
919positivegrowth37mesophilic

culture pH

  • @ref: 24963
  • ability: positive
  • type: maximum
  • pH: 4.5-5.0

Physiology and metabolism

oxygen tolerance

@refoxygen tolerance
919anaerobe
24963anaerobe
24963aerotolerant
44423anaerobe
116031anaerobe

spore formation

@refspore formationconfidence
24963no
69481no100
69480no99.993

compound production

  • @ref: 919
  • compound: LL diaminopimelic acid

murein

  • @ref: 919
  • murein short key: A41.01
  • type: A3gamma LL-Dpm-Gly

metabolite utilization

@refChebi-IDmetaboliteutilization activitykind of utilization tested
249634853esculin-hydrolysis
2496317306maltose-fermentation
2496333942ribose-fermentation
2496317992sucrose-fermentation
249635291gelatin+hydrolysis
2496317234glucose+fermentation
2496317754glycerol+fermentation
2496317632nitrate+reduction
2496330911sorbitol+fermentation
1160314853esculin-hydrolysis
11603117632nitrate+reduction
11603116301nitrite-reduction
6838016199urea-hydrolysis
6838016634raffinose-fermentation
6838029985L-glutamate-degradation
6838027897tryptophan+energy source

metabolite production

@refChebi-IDmetaboliteproduction
2496335581indoleyes
11603135581indoleyes
6838035581indoleyes

metabolite tests

@refChebi-IDmetaboliteindole testvoges-proskauer-test
6838035581indole+
11603115688acetoin-

enzymes

@refvalueactivityec
24963acid phosphatase+3.1.3.2
24963catalase+1.11.1.6
24963hyaluronidase+3.2.1.35
24963lecithinase+
24963lipase+
24963neuramindase+3.2.1.18
24963pyrrolidonyl arylamidase+3.4.19.3
24963ribonuclease+2.7.7.16
68380glutamyl-glutamate arylamidase-
68380histidine arylamidase-
68380glycin arylamidase+
68380alanine arylamidase+3.4.11.2
68380tyrosine arylamidase-
68380pyrrolidonyl arylamidase-3.4.19.3
68380leucine arylamidase-3.4.11.1
68380phenylalanine arylamidase-
68380proline-arylamidase+3.4.11.5
68380alkaline phosphatase-3.1.3.1
68380tryptophan deaminase+4.1.99.1
68380alpha-fucosidase-3.2.1.51
68380glutamate decarboxylase-4.1.1.15
68380beta-glucuronidase-3.2.1.31
68380alpha-arabinosidase-3.2.1.55
68380beta-glucosidase-3.2.1.21
68380alpha-glucosidase-3.2.1.20
68380beta-Galactosidase 6-phosphate-
68380alpha-galactosidase-3.2.1.22
68380urease-3.5.1.5
116031oxidase-
116031beta-galactosidase-3.2.1.23
116031gelatinase-
116031amylase-
116031DNase-
116031caseinase+3.4.21.50
116031catalase+1.11.1.6
116031tween esterase-
116031lecithinase+
116031lipase+
116031protease-
116031urease-3.5.1.5
68382alkaline phosphatase-3.1.3.1
68382esterase (C 4)+
68382esterase lipase (C 8)-
68382lipase (C 14)-
68382leucine arylamidase+3.4.11.1
68382valine arylamidase-
68382cystine arylamidase-3.4.11.3
68382trypsin-3.4.21.4
68382alpha-chymotrypsin-3.4.21.1
68382acid phosphatase+3.1.3.2
68382naphthol-AS-BI-phosphohydrolase+
68382alpha-galactosidase-3.2.1.22
68382beta-galactosidase+3.2.1.23
68382beta-glucuronidase-3.2.1.31
68382alpha-glucosidase+3.2.1.20
68382beta-glucosidase-3.2.1.21
68382N-acetyl-beta-glucosaminidase+3.2.1.52
68382alpha-mannosidase-3.2.1.24
68382alpha-fucosidase-3.2.1.51

API zym

@refControlAlkaline phosphataseEsteraseEsterase LipaseLipaseLeucine arylamidaseValine arylamidaseCystine arylamidaseTrypsinalpha- ChymotrypsinAcid phosphataseNaphthol-AS-BI-phosphohydrolasealpha- Galactosidasebeta- Galactosidasebeta- Glucuronidasealpha- Glucosidasebeta- GlucosidaseN-acetyl-beta- glucosaminidasealpha- Mannosidasealpha- Fucosidase
116031--+--+----++-+-+-+--

API rID32A

@refUREADH Argalpha GALbeta GALbeta GPalpha GLUbeta GLUalpha ARAbeta GURbeta NAGMNERAFGDCalpha FUCNITINDPALArgAProALGAPheALeuAPyrATyrAAlaAGlyAHisAGGASerA
919-+-+-----++---++-+++/-----++--+
919-+-+-----++---++-++-----++--+
919-+-+-----++---++--+-----++--+
919-+-+-----+----++--+-----++---
919-+-+/------++---++--+-----++--+
919-+-+-----++----+-+/-+-----++--+
919---+-----+/-+---++--+-----++--+
919-+-+-----++---++-++-----++--+
919-+-+-----++---+/-+--+-----++--+
919-+-+-----+/-+---++-+/-+-----++--+

API biotype100

@refGLUFRUGALTREMNESBEMELSACRAFMTEMALLACLTEMbGaMaGaCELGENMbGuESCRIBARAXYLPLERHAFUCMLZDARLLARLXLTDULTAGGLYINOMANMTLTURSORADOHBGLYXERYMDG3MDGSATMUCLTATDTATMTATDMLTLMLTCATETATETTECITGRTGAT2KG5KGTRYNAGGNTPACPATpOBEQATGTEmOBEBATPPATCMTTGEBETPCEABTHINLATCAPCYTHISSUCFUMGREGYTAVTETNTTNGLNITA3OBUAPTGTTPRODALALALASERMNTPROPTYR2KT
116031---------------------------------------------------------------------------------------------------

Isolation, sampling and environmental information

isolation

@refsample typegeographic locationcountryorigin.countrycontinentisolation date
919acne lesion in human facial skin
24963facial acneLondonUnited KingdomGBREurope
44423Human,facial acneUnited KingdomGBREurope
67770Facial acne
116031Facial acneLondonUnited KingdomGBREurope1920

isolation source categories

Cat1Cat2Cat3
#Host#Human
#Infection#Inflammation
#Host Body-Site#Organ#Skin, Nail, Hair

taxonmaps

  • @ref: 69479
  • File name: preview.99_663.png
  • url: https://microbeatlas.org/index.html?action=taxon&taxon_id=90_15360;96_410;97_465;98_535;99_663&stattab=map
  • Last taxonomy: Cutibacterium acnes
  • 16S sequence: AB538431
  • Sequence Identity:
  • Total samples: 60269
  • soil counts: 3573
  • aquatic counts: 7473
  • animal counts: 47966
  • plant counts: 1257

Safety information

risk assessment

@refbiosafety levelbiosafety level comment
9192Risk group (German classification)
1160311Risk group (French classification)

Sequence information

16S sequences

@refdescriptionaccessionlengthdatabaseNCBI tax ID
20218Propionibacterium acnes DNA, 16S-23S ribosomal RNA intergenic spacer region, strain: ATCC 6919AB108459222ena1747
20218Propionibacterium acnes ATCC 6919 16S rRNA gene, partial sequenceU02904387ena1747
20218Propionibacterium acnes strain CCUG 1794 clone 1 16S-23S ribosomal RNA intergenic spacer, partial sequenceGQ496473222ena1747
20218Propionibacterium acnes strain DSM 1897 16S ribosomal RNA gene, partial sequenceEF680378451ena1747
20218Propionibacterium acnes partial 16S rRNAX532181359ena1747
20218Propionibacterium acnes gene for 16S ribosomal RNA, partial sequence, strain: JCM 6425AB5384311486ena1747
919Propionibacterium acnes gene for 16S ribosomal RNA, ATCC6919AB0422881486ena1747

Genome sequences

@refdescriptionaccessionassembly leveldatabaseNCBI tax ID
66792Cutibacterium acnes ATCC 6919GCA_003030305completencbi1747
66792Cutibacterium acnes ATCC 6919GCA_008728435completencbi1747
66792Cutibacterium acnes DSM 1897GCA_004136195completencbi1122995
66792Cutibacterium acnes subsp. acnes NBRC 107605GCA_006739385completencbi1734925
66792Cutibacterium acnes ATCC 6919GCA_000730485contigncbi1747
66792Cutibacterium acnes DSM 18971122995.5completepatric1122995
66792Cutibacterium acnes strain ATCC 69191747.866completepatric1747
66792Cutibacterium acnes strain ATCC 69191747.234completepatric1747
66792Cutibacterium acnes subsp. acnes strain NBRC 1076051734925.62completepatric1734925
66792Propionibacterium acnes DSM 18971122995.3wgspatric1122995
66792Propionibacterium acnes strain ATCC 69191747.45wgspatric1747
66792Cutibacterium acnes NBRC 1076052888212034completeimg1747
66792Cutibacterium acnes ATCC 69192518285594draftimg1747
66792Cutibacterium acnes DSM 18972515154214draftimg1122995
66792Cutibacterium acnes ATCC 69192619619216draftimg1747
67770Cutibacterium acnes DSM 1897GCA_000472405contigncbi1122995

GC content

@refGC-contentmethod
91959.0
2496360genome sequence analysis

Genome-based predictions

predictions

traitpredictionconfidencetraining_data
spore-formingno100no
flagellatedno98.303yes
gram-positiveyes92.505yes
anaerobicyes59.016no
halophileno85.4no
spore-formingno91.161no
glucose-utilyes91.279no
aerobicno87.107no
thermophileno69.227yes
motileno94.255yes
glucose-fermentyes82.576yes

External links

@ref: 919

culture collection no.: LMG 16711, DSM 1897, ATCC 6919, CCUG 1794, JCM 6425, KCTC 3314, NCTC 737, BCRC 10723, CECT 5684, CGMCC 1.5003, CIP 53.117, KCTC 5008, LMG 3591, NBRC 107605, NRRL B-4224, VKM Ac-1450, VPI 0389

straininfo link

  • @ref: 81849
  • straininfo: 389260

literature

topicPubmed-IDtitleauthorsjournalDOIyearmeshtopic2
Metabolism539817Biotyping of Propionibacterium acnes isolated from normal human facial skin.Kishishita M, Ushijima T, Ozaki Y, Ito YAppl Environ Microbiol10.1128/aem.38.4.585-589.19791979Agglutination Tests, Erythritol/metabolism, Face, Fermentation, Humans, Japan, Propionibacterium acnes/*classification/metabolism, Ribose/metabolism, Serotyping, Skin/*microbiology, Sorbitol/metabolismPathogenicity
Enzymology11864945In vitro and in vivo antibacterial activity of T-3912, a novel non-fluorinated topical quinolone.Yamakawa T, Mitsuyama J, Hayashi KJ Antimicrob Chemother10.1093/jac/49.3.4552002Animals, Anti-Infective Agents/pharmacology/therapeutic use, Clindamycin/pharmacology/therapeutic use, Colony Count, Microbial, DNA Topoisomerase IV/antagonists & inhibitors, Drug Resistance, Bacterial/genetics, Erythromycin/pharmacology/therapeutic use, *Fluoroquinolones, Gene Frequency, Genes, Bacterial, Gentamicins/pharmacology/therapeutic use, Levofloxacin, Male, Mice, Mice, Inbred ICR, Microbial Sensitivity Tests, Mutation, Ofloxacin/pharmacology/therapeutic use, Quinolines/*pharmacology/*therapeutic use, Quinolizines/pharmacology/therapeutic use, Staphylococcal Skin Infections/*drug therapy, Staphylococcus aureus/*drug effects/enzymology/genetics, Staphylococcus epidermidis/*drug effects/enzymology/genetics, Topoisomerase II InhibitorsPathogenicity
Metabolism14602184Hydrogel patches containing triclosan for acne treatment.Lee TW, Kim JC, Hwang SJEur J Pharm Biopharm10.1016/s0939-6411(03)00137-12003Acne Vulgaris/*drug therapy/metabolism, Adhesives/administration & dosage, Administration, Cutaneous, Animals, Female, Hydrogel, Polyethylene Glycol Dimethacrylate/*administration & dosage/pharmacokinetics, Mice, Mice, Hairless, Skin/drug effects/metabolism, Triclosan/*administration & dosage/pharmacokineticsEnzymology
Metabolism15870447CAMP factor homologues in Propionibacterium acnes: a new protein family differentially expressed by types I and II.Valanne S, McDowell A, Ramage G, Tunney MM, Einarsson GG, O'Hagan S, Wisdom GB, Fairley D, Bhatia A, Maisonneuve JF, Lodes M, Persing DH, Patrick SMicrobiology (Reading)10.1099/mic.0.27788-02005Animals, Bacterial Proteins/chemistry/genetics/*metabolism, Base Sequence, DNA, Bacterial/analysis, *Gene Expression Regulation, Bacterial, Hemolysin Proteins, Humans, Mice, Molecular Sequence Data, Polymerase Chain Reaction/methods, Propionibacterium acnes/classification/genetics/growth & development/*metabolism, Sequence Analysis, DNA, Streptococcus agalactiae/genetics/metabolismPathogenicity
Pathogenicity16226831Effect of bacteriocin produced by Lactococcus sp. HY 449 on skin-inflammatory bacteria.Oh S, Kim SH, Ko Y, Sim JH, Kim KS, Lee SH, Park S, Kim YJFood Chem Toxicol10.1016/j.fct.2005.08.0302005Acne Vulgaris/*drug therapy/microbiology, Anti-Bacterial Agents/*pharmacology/therapeutic use, Bacteriocins/*pharmacology/therapeutic use, Humans, Lactococcus/*metabolism, Microbial Sensitivity Tests, Propionibacterium acnes/*drug effects, Staphylococcus/*drug effectsMetabolism
Pathogenicity16793484Effect of bacteriocin produced by Lactococcus sp. HY 449 on skin-inflammatory bacteria.Oh S, Kim SH, Ko Y, Sim JH, Kim KS, Lee SH, Park S, Kim YJFood Chem Toxicol10.1016/j.fct.2005.08.0082006Adult, Allantois/drug effects, Animals, Bacteriocins/isolation & purification/*pharmacology/toxicity, Chick Embryo, Cosmetics, Dermatitis/drug therapy/*microbiology, Dermatitis, Irritant/etiology, Female, Fibroblasts/drug effects, Gram-Positive Bacterial Infections/drug therapy/*microbiology, Humans, Lactococcus/*metabolism, Microbial Sensitivity Tests, Propionibacterium acnes/drug effects, Skin Diseases, Infectious/drug therapy/*microbiology, Skin Tests, Staphylococcus aureus/drug effects, Staphylococcus epidermidis/drug effects, Streptococcus pyogenes/drug effectsEnzymology
Pathogenicity17852906Biofilm formation of the pathogens of fatal bacterial granuloma after trauma: potential mechanism underlying the failure of traditional antibiotic treatments.Qi X, Gao J, Sun D, Liang W, Wan Y, Li C, Xu X, Gao TScand J Infect Dis10.1080/003655407016329982007Anti-Bacterial Agents/pharmacology/*therapeutic use, Biofilms/drug effects/*growth & development, Doxycycline/pharmacology/therapeutic use, Gram-Positive Bacterial Infections/*microbiology, Granuloma/*microbiology, Humans, Lincomycin/pharmacology/therapeutic use, Microbial Sensitivity Tests, Microbial Viability, Microscopy, Electron, Scanning, Propionibacterium acnes/drug effects/*growth & development/isolation & purification/ultrastructure, Wounds and Injuries/*complicationsEnzymology
Enzymology18057448Linoleic acid isomerase from Propionibacterium acnes: purification, characterization, molecular cloning, and heterologous expression.Deng MD, Grund AD, Schneider KJ, Langley KM, Wassink SL, Peng SS, Rosson RAAppl Biochem Biotechnol10.1007/s12010-007-8075-12007Animals, Chromatography, Gas, Chromatography, Ion Exchange, Cloning, Molecular, Escherichia coli/genetics, Fermentation, Gene Expression, Humans, Hydrophobic and Hydrophilic Interactions, Kinetics, Lactobacillus reuteri/enzymology, Linoleic Acid/*metabolism, Linoleic Acids, Conjugated/chemistry, Mass Spectrometry, Molecular Sequence Data, Polymerase Chain Reaction, Propionibacterium acnes/*enzymology, Recombinant Proteins/chemistry, cis-trans-Isomerases/chemistry/*genetics/isolation & purification/*metabolismPathogenicity
Phylogeny18201989A new phylogenetic group of Propionibacterium acnes.McDowell A, Perry AL, Lambert PA, Patrick SJ Med Microbiol10.1099/jmm.0.47489-02008Antibodies, Bacterial/metabolism, Antibodies, Monoclonal/metabolism, Cluster Analysis, DNA, Bacterial/chemistry/genetics, DNA, Ribosomal/chemistry/genetics, Gram-Positive Bacterial Infections/*microbiology, Humans, Microscopy, Fluorescence, Molecular Sequence Data, Phylogeny, Polymorphism, Genetic, Propionibacterium acnes/*classification/cytology/*genetics/isolation & purification, RNA, Ribosomal, 16S/genetics, Rec A Recombinases/genetics, Sequence Analysis, DNA, Sequence Homology, Nucleic Acid, SerotypingMetabolism
Enzymology19132369Characterization of beta-1,3-galactosyl-N-acetylhexosamine phosphorylase from Propionibacterium acnes.Nakajima M, Nishimoto M, Kitaoka MAppl Microbiol Biotechnol10.1007/s00253-008-1838-y2009Acetylglucosamine/analogs & derivatives/metabolism, Cloning, Molecular, DNA, Bacterial/chemistry/genetics, Disaccharides/metabolism, Enzyme Stability, Galactosyltransferases/*genetics/*metabolism, Hydrogen-Ion Concentration, Kinetics, Molecular Sequence Data, Phylogeny, Propionibacterium acnes/*enzymology/genetics, Sequence Analysis, DNA, Sequence Homology, Nucleic Acid, Substrate Specificity, TemperatureMetabolism
Enzymology19244908Cloning and expression of antibacterial goat lactoferricin from Escherichia coli AD494(DE3)pLysS expression system.Chen GH, Yin LJ, Chiang IH, Jiang STJ Food Prot10.4315/0362-028x-71.12.25232008Amino Acid Sequence, Animals, Anti-Bacterial Agents/*pharmacology, Cloning, Molecular, Consumer Product Safety, DNA, Complementary/analysis, Escherichia coli/*genetics/metabolism, Gene Expression, Genetic Vectors/genetics, Goats, Histidine, Humans, Lactoferrin/*pharmacology, Recombinant Fusion Proteins/*pharmacology, Sequence Analysis, DNA, Temperature, Time FactorsPathogenicity
Metabolism19282842Involvement of Propionibacterium acnes in the augmentation of lipogenesis in hamster sebaceous glands in vivo and in vitro.Iinuma K, Sato T, Akimoto N, Noguchi N, Sasatsu M, Nishijima S, Kurokawa I, Ito AJ Invest Dermatol10.1038/jid.2009.462009Acne Vulgaris/etiology, Animals, Cells, Cultured, Cricetinae, *Lipogenesis, Male, Mesocricetus, Propionibacterium acnes/*pathogenicity, Prostaglandin D2/analogs & derivatives/physiology, Sebaceous Glands/cytology/*metabolism, Sebum/physiology, Triglycerides/biosynthesis
Pathogenicity20045961Syntheses of carnosic acid and carnosol, anti-oxidants in Rosemary, from pisiferic acid, the major constituent of Sawara.Tada M, Ohkanda T, Kurabe JChem Pharm Bull (Tokyo)10.1248/cpb.58.272010Abietanes/*chemical synthesis/pharmacology, Anti-Bacterial Agents/*chemical synthesis/pharmacology, Antioxidants/*chemical synthesis, Chamaecyparis/chemistry, Diterpenes/chemistry, Plant Extracts/*chemical synthesis/pharmacology, Propionibacterium acnes/drug effects, Rosmarinus/*chemistry, Staphylococcus aureus/drug effects
Pathogenicity20697725Protease-activated receptor-2 mediates the expression of inflammatory cytokines, antimicrobial peptides, and matrix metalloproteinases in keratinocytes in response to Propionibacterium acnes.Lee SE, Kim JM, Jeong SK, Jeon JE, Yoon HJ, Jeong MK, Lee SHArch Dermatol Res10.1007/s00403-010-1074-z2010Acne Vulgaris/*immunology, Antigens, Bacterial/immunology, Antimicrobial Cationic Peptides/genetics/immunology/metabolism, Calcium Signaling/drug effects/immunology, Cell Line, Transformed, Cytokines/genetics/immunology/metabolism, Gene Expression Regulation/drug effects/immunology, Gram-Positive Bacterial Infections/*immunology, Humans, Inflammation Mediators/immunology/metabolism, Keratinocytes/drug effects/immunology/*metabolism/pathology, Matrix Metalloproteinases/genetics/immunology/metabolism, Propionibacterium acnes/*immunology, Receptor, PAR-2/antagonists & inhibitors/genetics/immunology/*metabolism, Serine Proteinase Inhibitors/pharmacologyMetabolism
Pathogenicity24289140Evaluation of antibacterial and anti-inflammatory activities of less polar ginsenosides produced from polar ginsenosides by heat-transformation.Wang L, Yang X, Yu X, Yao Y, Ren GJ Agric Food Chem10.1021/jf404461q2013Animals, Anti-Bacterial Agents/*chemistry/*pharmacology, Anti-Inflammatory Agents/*chemistry/*pharmacology, Cell Line, Ginsenosides/*chemistry/*pharmacology, Hot Temperature, Macrophages/drug effects/immunology, Mice, Microbial Sensitivity Tests, Molecular Structure, Propionibacterium acnes/drug effectsStress
Metabolism243274405alpha-Androst-16-en-3alpha-ol beta-D-glucuronide, precursor of 5alpha-androst-16-en-3alpha-ol in human sweat.Starkenmann C, Mayenzet F, Brauchli R, Troccaz MChem Biodivers10.1002/cbdv.2013002862013Androstenols/*analysis/*chemistry/metabolism, Apocrine Glands/chemistry/metabolism, Chromatography, High Pressure Liquid, Eccrine Glands/chemistry/metabolism, Female, Glucuronidase/metabolism, Glucuronides/*analysis/metabolism, Gram-Positive Bacteria/chemistry/metabolism, Humans, Male, Odorants/analysis, Spectrometry, Mass, Electrospray Ionization, Sweat/*chemistry/metabolismPathogenicity
Genetics25125638Draft Genome Sequences of Propionibacterium acnes Type Strain ATCC6919 and Antibiotic-Resistant Strain HL411PA1.Liu J, Cheng A, Bangayan NJ, Barnard E, Curd E, Craft N, Li HGenome Announc10.1128/genomeA.00740-142014
Pathogenicity25623849Antimicrobial photodynamic therapy using chlorin e6 with halogen light for acne bacteria-induced inflammation.Jeon YM, Lee HS, Jeong D, Oh HK, Ra KH, Lee MYLife Sci10.1016/j.lfs.2014.12.0292015Acne Vulgaris/*drug therapy/microbiology, Animals, Blotting, Western, Chlorophyllides, Cyclooxygenase 2/genetics, Cytokines/genetics, Disease Models, Animal, Dose-Response Relationship, Drug, Gene Expression Regulation, Halogens, Inflammation/*drug therapy/microbiology, Male, Mice, Mice, Inbred ICR, Nitric Oxide Synthase Type II/genetics, Photochemotherapy/adverse effects/*methods, Porphyrins/*administration & dosage, Propionibacterium acnes/*drug effects, Radiation-Sensitizing Agents/administration & dosage
Phylogeny26432704Dissecting the taxonomic heterogeneity within Propionibacterium acnes: proposal for Propionibacterium acnes subsp. acnes subsp. nov. and Propionibacterium acnes subsp. elongatum subsp. nov.Dekio I, Culak R, Misra R, Gaulton T, Fang M, Sakamoto M, Ohkuma M, Oshima K, Hattori M, Klenk HP, Rajendram D, Gharbia SE, Shah HNInt J Syst Evol Microbiol10.1099/ijsem.0.0006482015Bacterial Proteins/chemistry, Bacterial Typing Techniques, DNA, Bacterial/genetics, Fatty Acids/chemistry, Genes, Bacterial, Humans, Molecular Sequence Data, Nucleic Acid Hybridization, *Phylogeny, Propionibacterium acnes/*classification, RNA, Ribosomal, 16S/genetics, Ribosomal Proteins/chemistry, Sequence Analysis, DNA, Skin/microbiology, Spectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationPathogenicity
Pathogenicity26434141Chemical Composition of the Essential Oil from Croton oblongifolius and its Antibacterial Activity against Propionibacterium acnes.Athikomkulchai S, Tadtong S, Ruangrungsi N, Hongratanaworakit TNat Prod Commun2015Anti-Bacterial Agents/*chemistry/pharmacology, Croton/*chemistry, Oils, Volatile/*chemistry/pharmacology, Plant Leaves/chemistry, Plant Oils/*chemistry/pharmacology, Propionibacterium acnes/*drug effects
Phylogeny27259292Propionibacterium namnetense sp. nov., isolated from a human bone infection.Aubin GG, Bemer P, Kambarev S, Patel NB, Lemenand O, Caillon J, Lawson PA, Corvec SInt J Syst Evol Microbiol10.1099/ijsem.0.0012042016Bacterial Typing Techniques, Base Composition, Bone Diseases, Infectious/*microbiology, DNA, Bacterial/genetics, Fatty Acids/chemistry, France, Humans, Male, Nucleic Acid Hybridization, *Phylogeny, Propionibacterium/*classification/genetics/isolation & purification, RNA, Ribosomal, 16S/genetics, Sequence Analysis, DNA, Young AdultPathogenicity
Phylogeny27670798Emendation of Propionibacterium acnes subsp. acnes (Deiko et al. 2015) and proposal of Propionibacterium acnes type II as Propionibacterium acnes subsp. defendens subsp. nov.McDowell A, Barnard E, Liu J, Li H, Patrick SInt J Syst Evol Microbiol10.1099/ijsem.0.0015212016Bacterial Typing Techniques, CRISPR-Cas Systems, DNA, Bacterial/genetics, Genome, Bacterial, Multilocus Sequence Typing, Nucleic Acid Hybridization, *Phylogeny, Propionibacterium acnes/*classification, RNA, Ribosomal, 16S/genetics, Sequence Analysis, DNAGenetics
Proteome28083470Analysis of the Surface, Secreted, and Intracellular Proteome of Propionibacterium acnes.Yu Y, Champer J, Kim JEuPA Open Proteom10.1016/j.euprot.2015.06.0032015
Pathogenicity28218305Interaction of Cutibacterium ( formerly Propionibacterium) acnes with bone cells: a step toward understanding bone and joint infection development.Aubin GG, Baud'huin M, Lavigne JP, Brion R, Gouin F, Lepelletier D, Jacqueline C, Heymann D, Asehnoune K, Corvec SSci Rep10.1038/srep429182017Bone Diseases/microbiology/pathology, Cell Line, Tumor, Cell Survival, Gram-Positive Bacterial Infections/microbiology/pathology, Humans, Joint Diseases/microbiology/pathology, Monocytes/cytology/immunology/metabolism, Multilocus Sequence Typing, Propionibacterium acnes/genetics/isolation & purification/*physiology, Whole Genome SequencingMetabolism
Pathogenicity28237766N-acetylcysteine inhibits growth, adhesion and biofilm formation of Gram-positive skin pathogens.Eroshenko D, Polyudova T, Korobov VMicrob Pathog10.1016/j.micpath.2017.02.0302017Acetylcysteine/*pharmacology, Adhesins, Bacterial/metabolism, Anti-Bacterial Agents/*pharmacology, Biofilms/*drug effects, Drug Resistance, Bacterial, Gram-Negative Bacteria/cytology/*drug effects/metabolism/physiology, Gram-Negative Bacterial Infections/microbiology, Gram-Positive Bacteria/cytology/*drug effects/metabolism/physiology, Gram-Positive Bacterial Infections/microbiology, Humans, Microbial Sensitivity Tests, Skin/*microbiology, Skin Diseases, Bacterial/microbiologyMetabolism
Pathogenicity28605136A Polycation Antimicrobial Peptide Mimic without Resistance Buildup against Propionibacterium Acnes.Nair SS, Zolotarskaya OY, Beckwith MJ, Ohman DE, Wynne KJMacromol Biosci10.1002/mabi.2017000902017Acne Vulgaris, Anti-Infective Agents/pharmacology, Antimicrobial Cationic Peptides/*pharmacology, Drug Resistance, Microbial, Humans, Microbial Sensitivity Tests, Polyamines/pharmacology, Polyelectrolytes, Propionibacterium acnes/*drug effects
Pathogenicity28627377Mikania glomerata Sprengel extract and its major compound ent-kaurenoic acid display activity against bacteria present in endodontic infections.Moreti DLC, Leandro LF, da Silva Moraes T, Moreira MR, Sola Veneziani RC, Ambrosio SR, Gomes BP, Martins CHGAnaerobe10.1016/j.anaerobe.2017.06.0082017Anti-Bacterial Agents/isolation & purification/*pharmacology, Bacteria/*drug effects/isolation & purification, Bacterial Infections/*microbiology, Biofilms/drug effects, Brazil, Chlorhexidine/pharmacology, Diterpenes/isolation & purification/*pharmacology, Drug Synergism, Humans, Microbial Sensitivity Tests, Microbial Viability/drug effects, Mikania/*chemistry, Plant Extracts/isolation & purification/*pharmacology, Pulpitis/*microbiologyEnzymology
Pathogenicity30315257Synthesis and evaluation of biological activity of benzoxaborole derivatives of azithromycin.Tevyashova AN, Korolev AM, Mirchink EP, Isakova EB, Osterman IAJ Antibiot (Tokyo)10.1038/s41429-018-0107-22018Anti-Bacterial Agents/chemical synthesis/chemistry/*pharmacology, Azithromycin/*analogs & derivatives/chemical synthesis/chemistry/*pharmacology, Gram-Negative Bacteria/drug effects, Gram-Positive Bacteria/*drug effects, Microbial Sensitivity Tests, Molecular Structure, Peptide Biosynthesis/drug effects
32082144Exploring the Anti-Acne Potential of Impepho [Helichrysum odoratissimum (L.) Sweet] to Combat Cutibacterium acnes Virulence.De Canha MN, Komarnytsky S, Langhansova L, Lall NFront Pharmacol10.3389/fphar.2019.015592020
Pathogenicity32138302Rosa davurica Pall. Improves Propionibacterium acnes-Induced Inflammatory Responses in Mouse Ear Edema Model and Suppresses Pro-Inflammatory Chemokine Production via MAPK and NF-kappaB Pathways in HaCaT Cells.Hwang DH, Lee DY, Koh PO, Yang HR, Kang C, Kim EInt J Mol Sci10.3390/ijms210517172020Animals, Anti-Inflammatory Agents/*chemistry/*therapeutic use, Cell Line, Tumor, Disease Models, Animal, Edema/drug therapy/*immunology, Gram-Positive Bacterial Infections/*drug therapy/*immunology/microbiology, Humans, Mice, Mitogen-Activated Protein Kinases/metabolism, NF-kappa B/metabolism, Propionibacterium acnes/immunology/*pathogenicity, Rosa/*chemistryMetabolism
Metabolism32543022Caenorhabditis elegans mounts a p38 MAPK pathway-mediated defence to Cutibacterium acnes infection.Huang X, Pan W, Kim W, White A, Li S, Li H, Lee K, Fuchs BB, Zeng K, Mylonakis ECell Microbiol10.1111/cmi.132342020Animals, Caenorhabditis elegans/immunology/*metabolism/*microbiology, Caenorhabditis elegans Proteins/genetics/*metabolism, Down-Regulation, Immunity, Innate, Lectins, C-Type/genetics/*metabolism, MAP Kinase Kinase 4/metabolism, *MAP Kinase Signaling System, Mitogen-Activated Protein Kinases/metabolism, Phosphorylation, Propionibacteriaceae/*pathogenicity, Receptors, G-Protein-Coupled/metabolism, p38 Mitogen-Activated Protein Kinases/*metabolism
Genetics32675190Complete Genome Sequences and Methylome Analyses of Cutibacterium acnes subsp. acnes Strains DSM 16379 and DSM 1897(T).Deptula P, Laine P, Paulin L, Auvinen P, Roberts RJ, Johnston CD, Varmanen PMicrobiol Resour Announc10.1128/MRA.00705-202020
Enzymology33152431Saponin fraction from Sapindus mukorossi Gaertn as a novel cosmetic additive: Extraction, biological evaluation, analysis of anti-acne mechanism and toxicity prediction.Wei MP, Qiu JD, Li L, Xie YF, Yu H, Guo YH, Yao WRJ Ethnopharmacol10.1016/j.jep.2020.1135522020Acne Vulgaris/diagnosis/*drug therapy/microbiology, Adult, Cosmetics/*administration & dosage/isolation & purification/toxicity, Drug Evaluation, Preclinical/methods, Female, Forecasting, Humans, Male, Microbial Sensitivity Tests/methods, Plant Extracts/*administration & dosage/isolation & purification/toxicity, Propionibacterium acnes/*drug effects/physiology, *Sapindus, Saponins/*administration & dosage/isolation & purification/toxicity, Young AdultPhylogeny
Pathogenicity33275348Evaluation of tea tree oil physicochemical features and its antimicrobial activity against Cutibacterium acnes (Propionibacterium acnes) ATCC 6919Ossa-Tabares JC, Llanos CJ, Garcia AMBiomedica10.7705/biomedica.51222020Anti-Infective Agents, Local/*chemistry/*pharmacology/standards, Color, Flame Ionization, Microbial Sensitivity Tests, Propionibacterium acnes/*drug effects/growth & development, Refractometry, Tea Tree Oil/administration & dosage/chemistry/*pharmacology/standards, Terpenes/analysis
33529773Effectiveness of topical adjuvants in reducing biofilm formation on orthopedic implants: an in vitro analysis.Kia C, Cusano A, Messina J, Muench LN, Chadayammuri V, McCarthy MB, Umejiego E, Mazzocca ADJ Shoulder Elbow Surg10.1016/j.jse.2020.12.0092021Animals, Biofilms, Prostheses and Implants, *Prosthesis-Related Infections/prevention & control, Sheep, Staphylococcus aureus, Staphylococcus epidermidis
Pathogenicity33580963Interaction of implant infection-related commensal bacteria with mesenchymal stem cells: a comparison between Cutibacterium acnes and Staphylococcus aureus.El-Mahdy TS, Mongaret C, Varin-Simon J, Lamret F, Vernet-Garnier V, Rammal H, Mauprivez C, Kerdjoudj H, Gangloff SC, Reffuveille FFEMS Microbiol Lett10.1093/femsle/fnab0142021Biofilms/growth & development, Cell Survival, Cytoplasm/microbiology, Host-Pathogen Interactions, Humans, Mesenchymal Stem Cells/*microbiology, Propionibacterium acnes/*physiology, Prosthesis-Related Infections/microbiology, Staphylococcus aureus/*physiology
Cultivation34703120Coculture method for in vitro cultivation of uncultured oral bacteria.Kusugal P, Bhat KG, Ingalagi P, Patil S, Pattar GJ Oral Maxillofac Pathol10.4103/0973-029X.3251252021
35625309Efficacy of Three Povidone Iodine Formulations against Cutibacterium acnes Assessed through In Vitro Studies: A Preliminary Study.Pichon M, Burucoa C, Evplanov V, Favalli FAntibiotics (Basel)10.3390/antibiotics110506652022

Reference

@idauthorscataloguedoi/urltitlejournalpubmed
919Curators of the DSMZLeibniz Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH (DSM 1897)https://www.dsmz.de/collection/catalogue/details/culture/DSM-1897
20215Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M.10.1099/ijsem.0.004332List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ
20218Verslyppe, B., De Smet, W., De Baets, B., De Vos, P., Dawyndt P.10.1016/j.syapm.2013.11.002StrainInfo introduces electronic passports for microorganisms.Syst Appl Microbiol. 37: 42-50 201424321274
24963C. F. P. K. Scholz, Mogens10.1099/ijsem.0.001367The natural history of cutaneous propionibacteria, and reclassification of selected species within the genus Propionibacterium to the proposed novel genera Acidipropionibacterium gen. nov., Cutibacterium gen. nov. and Pseudopropionibacterium gen. nov.IJSEM 66: 4422-4432 201627488827
42199Curators of the CIPhttps://brclims.pasteur.fr/brcWeb/souche/detail/1/16567
44423Curators of the CCUGCulture Collection University of Gothenburg (CCUG) (CCUG 1794)https://www.ccug.se/strain?id=1794
66792Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmannhttps://diaspora-project.de/progress.html#genomesAutomatically annotated for the DiASPora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information)
67770Curators of the JCMhttps://jcm.brc.riken.jp/en/
68380Automatically annotated from API rID32A
68382Automatically annotated from API zym
69479João F Matias Rodrigues, Janko Tackmann,Gregor Rot, Thomas SB Schmidt, Lukas Malfertheiner, Mihai Danaila,Marija Dmitrijeva, Daniela Gaio, Nicolas Näpflin and Christian von Mering. University of Zurich.https://microbeatlas.org/MicrobeAtlas 1.0 beta
69480Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmannhttps://diaspora-project.de/progress.html#genomesPredictions based on genome sequence made in the Diaspora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information)
69481Xiao-Yin To, René Mreches, Martin Binder, Alice C. McHardy, Philipp C. Münch10.21203/rs.3.rs-2527258/v1Predictions based on the model GenomeNet Sporulation v. 1
81849Reimer, L.C., Lissin, A.,Schober, I., Witte,J.F., Podstawka, A., Lüken, H., Bunk, B.,Overmann, J.10.60712/SI-ID389260.1StrainInfo: A central database for resolving microbial strain identifiers
116031Curators of the CIPCollection of Institut Pasteur (CIP 53.117)https://catalogue-crbip.pasteur.fr/fiche_catalogue.xhtml?crbip=CIP%2053.117